Discover open access scientific publications

Search, annotate, share and cite publications

Publications by Xiaocheng Ma

Significance of Cyclooxygenase‑2, Prostaglandin E2 and CD133 Levels in Sunitinib‑resistant Renal Cell Carcinoma

Oncology Letters

Cancer Research

English

Related publications

Sunitinib in the Treatment of Metastatic Renal Cell Carcinoma

Therapeutic Advances in Urology

English

Arachidonic Acid Is Preferentially Metabolized by Cyclooxygenase-2 to Prostacyclin and Prostaglandin E2

Journal of Biological Chemistry

Molecular Biology

English

Cyclooxygenase-2 (COX-2); Prostaglandin E2 (PGE2); VEGF Receptor 2 (KDR/Flk-1; VEGFR-2)

Science-Business eXchange

English

Fibroblast Growth Factor Receptor-Dependent and -Independent Paracrine Signaling by Sunitinib-Resistant Renal Cell Carcinoma

Molecular and Cellular Biology

Molecular Biology

English

A Phase 2 Trial of Sunitinib in Patients With Advanced Non–clear Cell Renal Cell Carcinoma

European Urology

English

Cox-2 Inhibition Enhances the Activity of Sunitinib in Human Renal Cell Carcinoma Xenografts

British Journal of Cancer

Cancer Research

English

Mp92-07 Netrin-1: A Novel Protein Identified in Disease Progression of Sunitinib Resistant Renal Cell Carcinoma

Journal of Urology

English

Phase I Trial of Sunitinib and Temsirolimus in Metastatic Renal Cell Carcinoma

Clinical Genitourinary Cancer

English

Adjuvant Sunitinib in High-Risk Renal-Cell Carcinoma After Nephrectomy

New England Journal of Medicine

English